Versetti Family Office, led by Angel Versetti, invests in biotech startups focusing on telomerase and follistatin gene therapies, cellular reprogramming, and diagnostic tools to measure biological age, providing funding and strategic support to extend healthspan.

Key points

• Platform trials test telomerase and follistatin gene therapies aiming to extend telomere length and enhance muscle regeneration.
• Cellular reprogramming approaches rejuvenate cells, tracked by next-generation biological age diagnostics in real time.
• Pre-seed funding and operational support accelerate biotech startups developing AI-driven personalized medicine for healthspan extension.